Nylon-3 polymers active against drug-resistant Candida albicans biofilms

Area of Science:

• Mycology
• Polymer Science
• Antimicrobial Research

Background:

• Candida albicans is a major human fungal pathogen, frequently causing disease through biofilms.
• Previous research developed nylon-3 polymers with high selectivity and efficacy against planktonic C. albicans.
• Biofilm-associated infections present significant therapeutic challenges due to inherent drug resistance.

Purpose of the Study:

• To evaluate the efficacy of nylon-3 polymers against drug-resistant Candida albicans in biofilms.
• To assess the polymers' ability to inhibit biofilm formation and eradicate mature biofilms.
• To compare the performance of the lead nylon-3 polymer against established antifungal drugs.

Main Methods:

• Testing of nylon-3 polymers, specifically poly-βNM, against multiple strains of Candida albicans.
• Assessing biofilm inhibition and killing of C. albicans within mature biofilms.
• Comparative analysis against fluconazole and amphotericin B (AmpB) for efficacy.

Main Results:

• Nylon-3 polymers demonstrated strong and selective activity against C. albicans in biofilms.
• Poly-βNM significantly inhibited biofilm formation and eradicated C. albicans from mature biofilms.
• Poly-βNM outperformed fluconazole against all tested strains and was superior to AmpB against an AmpB-resistant strain.

Conclusions:

• Nylon-3 polymers represent a promising therapeutic strategy for combating Candida albicans biofilm infections.
• The selective activity and efficacy against drug-resistant strains highlight their potential clinical utility.
• Poly-βNM offers a potent alternative or adjunct to current antifungal treatments for challenging C. albicans biofilms.